VERMILION ENERGY INC (VET.CA) Stock Fundamental Analysis

TSX:VET • CA9237251058

15.53 CAD
+1 (+6.88%)
Last: Mar 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

VET gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. VET has a medium profitability rating, but doesn't score so well on its financial health evaluation. VET is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • VET had negative earnings in the past year.
  • VET had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VET reported negative net income in multiple years.
  • Each year in the past 5 years VET had a positive operating cash flow.
VET.CA Yearly Net Income VS EBIT VS OCF VS FCFVET.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

  • VET has a Return On Assets (-3.93%) which is comparable to the rest of the industry.
  • VET has a Return On Equity (-8.65%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.20%, VET is in line with its industry, outperforming 58.10% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for VET is above the industry average of 6.66%.
  • The last Return On Invested Capital (3.20%) for VET is well below the 3 year average (9.77%), which needs to be investigated, but indicates that VET had better years and this may not be a problem.
Industry RankSector Rank
ROA -3.93%
ROE -8.65%
ROIC 3.2%
ROA(3y)4.74%
ROA(5y)-0.65%
ROE(3y)9.7%
ROE(5y)-15.85%
ROIC(3y)9.77%
ROIC(5y)N/A
VET.CA Yearly ROA, ROE, ROICVET.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • VET's Operating Margin of 12.83% is fine compared to the rest of the industry. VET outperforms 60.48% of its industry peers.
  • VET's Operating Margin has improved in the last couple of years.
  • The Gross Margin of VET (67.54%) is better than 82.38% of its industry peers.
  • VET's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.83%
PM (TTM) N/A
GM 67.54%
OM growth 3Y-29.16%
OM growth 5Y2.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.52%
GM growth 5Y0.95%
VET.CA Yearly Profit, Operating, Gross MarginsVET.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • VET has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for VET has been reduced compared to 1 year ago.
  • VET has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for VET is higher compared to a year ago.
VET.CA Yearly Shares OutstandingVET.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VET.CA Yearly Total Debt VS Total AssetsVET.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.56, we must say that VET is in the distress zone and has some risk of bankruptcy.
  • VET has a Altman-Z score (0.56) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.49 indicates that VET is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.49, VET is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC0.42
WACC7.53%
VET.CA Yearly LT Debt VS Equity VS FCFVET.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.81 indicates that VET may have some problems paying its short term obligations.
  • VET has a Current ratio (0.81) which is in line with its industry peers.
  • VET has a Quick Ratio of 0.81. This is a bad value and indicates that VET is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VET has a Quick ratio of 0.71. This is comparable to the rest of the industry: VET outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.71
VET.CA Yearly Current Assets VS Current LiabilitesVET.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • VET shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.33%, which is quite impressive.
  • VET shows a decrease in Revenue. In the last year, the revenue decreased by -2.34%.
  • The Revenue has been growing slightly by 1.65% on average over the past years.
EPS 1Y (TTM)70.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.94%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.42%
Revenue growth 5Y1.65%
Sales Q2Q%-5.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 70.83% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, VET will show a decrease in Revenue. The Revenue will decrease by -0.60% on average per year.
EPS Next Y-275.38%
EPS Next 2Y100.78%
EPS Next 3Y70.83%
EPS Next 5YN/A
Revenue Next Year-3.23%
Revenue Next 2Y-2.77%
Revenue Next 3Y-1.87%
Revenue Next 5Y-0.6%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VET.CA Yearly Revenue VS EstimatesVET.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
VET.CA Yearly EPS VS EstimatesVET.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • VET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 25.49, VET can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VET is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.11, VET is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 25.49
VET.CA Price Earnings VS Forward Price EarningsVET.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VET indicates a rather cheap valuation: VET is cheaper than 90.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.15
VET.CA Per share dataVET.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VET's earnings are expected to grow with 70.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100.78%
EPS Next 3Y70.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.69%, VET has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 4.11, VET pays a bit more dividend than its industry peers.
  • VET's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.69%

5.2 History

  • The dividend of VET decreases each year by -28.87%.
  • VET has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of VET decreased in the last 3 years.
Dividend Growth(5Y)-28.87%
Div Incr Years2
Div Non Decr Years2
VET.CA Yearly Dividends per shareVET.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of VET are negative and hence is the payout ratio. VET will probably not be able to sustain this dividend level.
DP-32.97%
EPS Next 2Y100.78%
EPS Next 3Y70.83%
VET.CA Yearly Income VS Free CF VS DividendVET.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

More info and screens

Find the best dividend stocksShow peers with best dividend

VERMILION ENERGY INC

TSX:VET (3/2/2026, 7:00:00 PM)

15.53

+1 (+6.88%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05
Earnings (Next)N/A
Inst Owners45.98%
Inst Owner ChangeN/A
Ins Owners0.49%
Ins Owner ChangeN/A
Market Cap2.79B
Revenue(TTM)1.89B
Net Income(TTM)-234.26M
Analysts70.67
Price Target14.84 (-4.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.69%
Yearly Dividend0.46
Dividend Growth(5Y)-28.87%
DP-32.97%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-914.6%
Min EPS beat(2)-1768.81%
Max EPS beat(2)-60.4%
EPS beat(4)0
Avg EPS beat(4)-502.97%
Min EPS beat(4)-1768.81%
Max EPS beat(4)-58.17%
EPS beat(8)0
Avg EPS beat(8)-396.27%
EPS beat(12)3
Avg EPS beat(12)1290.22%
EPS beat(16)5
Avg EPS beat(16)978.47%
Revenue beat(2)0
Avg Revenue beat(2)-22.1%
Min Revenue beat(2)-26.83%
Max Revenue beat(2)-17.37%
Revenue beat(4)0
Avg Revenue beat(4)-13.81%
Min Revenue beat(4)-26.83%
Max Revenue beat(4)-4.34%
Revenue beat(8)0
Avg Revenue beat(8)-14.17%
Revenue beat(12)0
Avg Revenue beat(12)-11.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.24%
PT rev (1m)4.24%
PT rev (3m)8.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-357.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-2.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.49
P/S 1.47
P/FCF N/A
P/OCF 2.72
P/B 1.03
P/tB 1.03
EV/EBITDA 4.15
EPS(TTM)-1.51
EYN/A
EPS(NY)0.61
Fwd EY3.92%
FCF(TTM)-3.98
FCFYN/A
OCF(TTM)5.7
OCFY36.71%
SpS10.54
BVpS15.09
TBVpS15.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.93%
ROE -8.65%
ROCE 4.44%
ROIC 3.2%
ROICexc 3.23%
ROICexgc 3.23%
OM 12.83%
PM (TTM) N/A
GM 67.54%
FCFM N/A
ROA(3y)4.74%
ROA(5y)-0.65%
ROE(3y)9.7%
ROE(5y)-15.85%
ROIC(3y)9.77%
ROIC(5y)N/A
ROICexc(3y)9.85%
ROICexc(5y)N/A
ROICexgc(3y)9.85%
ROICexgc(5y)N/A
ROCE(3y)13.57%
ROCE(5y)N/A
ROICexgc growth 3Y-31.83%
ROICexgc growth 5Y4.7%
ROICexc growth 3Y-31.83%
ROICexc growth 5Y4.7%
OM growth 3Y-29.16%
OM growth 5Y2.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.52%
GM growth 5Y0.95%
F-Score5
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA 1.4
Cap/Depr 248.72%
Cap/Sales 91.78%
Interest Coverage 1.99
Cash Conversion 108.73%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.71
Altman-Z 0.56
F-Score5
WACC7.53%
ROIC/WACC0.42
Cap/Depr(3y)126.62%
Cap/Depr(5y)107.23%
Cap/Sales(3y)33.7%
Cap/Sales(5y)32.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.94%
EPS Next Y-275.38%
EPS Next 2Y100.78%
EPS Next 3Y70.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.42%
Revenue growth 5Y1.65%
Sales Q2Q%-5.34%
Revenue Next Year-3.23%
Revenue Next 2Y-2.77%
Revenue Next 3Y-1.87%
Revenue Next 5Y-0.6%
EBIT growth 1Y21.86%
EBIT growth 3Y-30.87%
EBIT growth 5Y4.51%
EBIT Next Year60.33%
EBIT Next 3Y15.06%
EBIT Next 5Y15.47%
FCF growth 1Y-271.43%
FCF growth 3Y0.4%
FCF growth 5Y4.86%
OCF growth 1Y-13.01%
OCF growth 3Y5.06%
OCF growth 5Y3.28%

VERMILION ENERGY INC / VET.CA FAQ

What is the fundamental rating for VET stock?

ChartMill assigns a fundamental rating of 3 / 10 to VET.CA.


Can you provide the valuation status for VERMILION ENERGY INC?

ChartMill assigns a valuation rating of 2 / 10 to VERMILION ENERGY INC (VET.CA). This can be considered as Overvalued.


How profitable is VERMILION ENERGY INC (VET.CA) stock?

VERMILION ENERGY INC (VET.CA) has a profitability rating of 5 / 10.


What is the earnings growth outlook for VERMILION ENERGY INC?

The Earnings per Share (EPS) of VERMILION ENERGY INC (VET.CA) is expected to decline by -275.38% in the next year.